The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Jose Paulo Simao Henriques
Showing 1-20 of 22 articles
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
Kerkmeijer L,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout K,
Kraak R,
Weevers A,
Piek J,
de Winter RJ,
Tijssen J,
Henriques J,
Wykrzykowska JJ,
Ijsselmuiden A,
Kauer F,
Beijk MA,
Vis MM,
Koch K
September 20, 2019 | 10.4244/EIJ-D-19-00325
Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI
Tijssen R,
Kraak R,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Elias J,
van Dongen I,
Koch K,
Baan Jr J,
Vis MM,
de Winter RJ,
Piek J,
Tijssen J,
Henriques J,
Wykrzykowska JJ
July 20, 2018 | 10.4244/EIJ-D-18-00335
Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial
Tijssen R,
Kraak R,
Elias J,
van Dongen I,
Kalkman D,
Nassif M,
Sotomi Y,
Asano T,
Katagiri Y,
Collet C,
Piek J,
Henriques J,
de Winter RJ,
Tijssen J,
Onuma Y,
Serruys P,
Wykrzykowska JJ
July 20, 2018 | 10.4244/EIJ-D-17-01152
Acute myocardial infarction, chronic total occlusion, and cardiogenic shock: the ultimate triple threat
Claessen B,
Henriques J
June 14, 2018 | 10.4244/EIJV14I3A42
Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials
Cassese S,
Byrne R,
Jüni P,
Wykrzykowska JJ,
Puricel S,
Ndrepepa G,
Schunkert H,
Fusaro M,
Cook S,
Kimura T,
Henriques J,
Serruys P,
Windecker S,
Kastrati A
January 19, 2018 | 10.4244/EIJ-D-17-00492
Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: a propensity score analysis from the “real-life” BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry
Quadri G,
D’ascenzo F,
Moretti C,
D’Amico M,
Raposeiras-Roubin S,
Abu-Assi E,
Henriques J,
Saucedo J,
Gonzalez-Juanatey J,
Wilton S,
Kikkert WJ,
Núñez-Gil I,
Ariza-Sole A,
Song X,
Alexopoulos D,
Liebetrau C,
Kawaji T,
Huczek Z,
Nie S,
Fujii T,
Correia L,
Kawashiri M-a,
Garcia-Acuna J,
Southern D,
Alfonso E,
Terol B,
Garay A,
Zhang D,
Chen Y,
Xanthopoulou I,
Osman N,
Möllmann H,
Shiomi H,
Omedè P,
Montefusco A,
Giordana F,
Scarano S,
Kowara M,
Filipiak K,
Wang X,
Yan Y,
Fan J-Y,
Ikari Y,
Nakahayshi T,
Sakata K,
Yamagishi M,
Kalpak O,
Kedev S,
Varbella F,
Gaita F
July 20, 2017 | 10.4244/EIJ-D-16-00350
Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria
Kraak R,
Grundeken M.J,
Hassell M,
Elias J,
Koch K,
Henriques J,
Piek J,
Baan Jr J,
Vis MM,
Thijssen J,
de Winter RJ,
Wykrzykowska JJ
August 5, 2016 | 10.4244/EIJV12I5A95
The impact of the location of a chronic total occlusion in a non-infarct-related artery on long-term mortality in ST-elevation myocardial infarction patients
Hoebers L,
Elias J,
van Dongen I,
Ouweneel D,
Claessen B,
Piek J,
Henriques J
July 20, 2016 | 10.4244/EIJV12I4A75
Basal stenosis resistance index derived from simultaneous pressure and flow velocity measurements
van de Hoef TP,
Petraco R,
van Lavieren M,
Nijjer S,
Nolte F,
Sen S,
Echavarria-Pinto M,
Henriques J,
Koch K,
Baan Jr J,
de Winter RJ,
Siebes M,
Spaan J,
Thijssen J,
Meuwissen M,
Escaned J,
Davies J,
Piek J
June 10, 2016 | 10.4244/EIJV12I2A33
Head-to-head comparison of basal stenosis resistance index, instantaneous wave-free ratio, and fractional flow reserve: diagnostic accuracy for stenosis-specific myocardial ischaemia
van de Hoef TP,
Meuwissen M,
Escaned J,
Sen S,
Petraco R,
van Lavieren M,
Echavarria-Pinto M,
Nolte F,
Nijjer S,
Chamuleau S,
Voskuil M,
van Eck-Smit B,
Verberne H,
Henriques J,
Koch K,
de Winter RJ,
Spaan J,
Siebes M,
Thijssen J,
Davies J,
Piek J
December 20, 2015 | 10.4244/EIJY14M08_17
Treatment of coronary bifurcation lesions with the Absorb bioresorbable vascular scaffold in combination with the Tryton dedicated coronary bifurcation stent: evaluation using two- and three-dimensional optical coherence tomography
Grundeken M.J,
Hassell M,
Kraak R,
de Bruin D,
Koch K,
Henriques J,
van Leeuwen T,
Thijssen J,
Piek J,
de Winter RJ,
Wykrzykowska JJ
December 20, 2015 | 10.4244/EIJY14M08_15
Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Teeuwen K,
Van den Branden B,
Koolen J,
van der Schaaf R,
Henriques J,
Thijssen J,
Kelder J,
Vermeersch P,
Rensing B,
Suttorp MJ
March 20, 2015 | 10.4244/EIJY14M08_07
Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry
Kraak R,
Hassell M,
Grundeken M.J,
Koch K,
Henriques J,
Piek J,
Baan Jr J,
Vis MM,
Arkenbout EK,
Thijssen J,
de Winter RJ,
Wykrzykowska JJ
February 20, 2015 | 10.4244/EIJY14M08_08
Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitus
Hoebers L,
Claessen B,
Woudstra P,
De Vries J,
Wykrzykowska JJ,
Vis MM,
Baan Jr J,
Koch K,
Thijssen J,
de Winter RJ,
Piek J,
Henriques J
May 20, 2014 | 10.4244/EIJV10I1A15
Increased hyperaemic coronary microvascular resistance adds to the presence of myocardial ischaemia
Nolte F,
van de Hoef TP,
Meuwissen M,
Voskuil M,
Chamuleau S,
Henriques J,
Verberne H,
van Eck-Smit B,
Koch K,
de Winter RJ,
Spaan J,
Thijssen J,
Siebes M,
Piek J
April 22, 2014 | 10.4244/EIJV9I12A240
Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III): a randomised comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Van den Branden B,
Teeuwen K,
Koolen J,
van der Schaaf R,
Henriques J,
Thijssen J,
Kelder J,
Vermeersch P,
Rensing B,
Suttorp MJ
November 29, 2013 | 10.4244/EIJV9I7A138
Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies
Grundeken M.J,
Asgedom S,
Damman P,
Lesiak M,
Norell M,
Garcia E,
Bethencourt A,
Woudstra P,
Koch K,
Vis MM,
Henriques J,
Onuma Y,
Foley DP,
Bartorelli AL,
Stella P,
Thijssen J,
de Winter RJ,
Wykrzykowska JJ
June 28, 2013 | 10.4244/EIJV9I2A34
Acute haemodynamic effects of accelerated idioventricular rhythm in primary percutaneous coronary intervention
Delewi R,
Remmelink M,
Meuwissen M,
van Royen N,
Vis MM,
Koch K,
Henriques J,
de Winter RJ,
Thijssen J,
Baan Jr J,
Piek J
August 30, 2011 | 10.4244/EIJV7I4A76
Long-term safety and sustained left ventricular recovery: long-term results of percutaneous left ventricular support with Impella LP2.5 in ST-elevation myocardial infarction
Engstrom A,
Sjauw K,
Baan Jr J,
Remmelink M,
Claessen B,
Kikkert WJ,
Hoebers L,
Vis MM,
Koch K,
Meuwissen M,
Thijssen J,
de Winter RJ,
Piek J,
Henriques J
February 21, 2011
The effect of repeated ischaemic periods on left ventricular dynamics during percutaneous coronary intervention
Remmelink M,
de Winter RJ,
Henriques J,
Koch K,
van der Schaaf R,
Vis MM,
Thijssen J,
Piek J,
Baan Jr J
November 15, 2010
1
2
Latest news
AHEAD OF PRINT
Diagnostic accuracy of OFR
FREE ARTICLE - Fukang Hu et al
March 23, 2023
#EIJonAir - Renal denervation in the management of hypertension
March 22, 2023
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Contemporary transcatheter prostheses in small annuli
FREE ARTICLE - Pier Pasquale Leone et al
March 21, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
AHEAD OF PRINT
Posterior pericardiotomy for the prevention of atrial fibrillation
FREE ARTICLE - Ahmed AbdelAziz et al
March 16, 2023
AHEAD OF PRINT
One-year outcomes with the Mistral device
FREE ARTICLE - Kerstin Piayda et al
March 13, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke